NZ313076A
(en)
*
|
1995-07-24 |
1999-11-29 |
Lilly Co Eli |
Medicament containing duloxetine for treating hyperactivity and attention deficiency disorders
|
US5910319A
(en)
*
|
1997-05-29 |
1999-06-08 |
Eli Lilly And Company |
Fluoxetine enteric pellets and methods for their preparation and use
|
AU746887B2
(en)
*
|
1998-09-15 |
2002-05-02 |
Eli Lilly And Company |
Treatment of persistent pain
|
DE60039377D1
(de)
*
|
1999-02-09 |
2008-08-21 |
Pfizer Prod Inc |
Zusammensetzungen basischer Arzneistoffe mit verbesserter Bioverfügbarkeit
|
IL130602A0
(en)
*
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
KR20020081403A
(ko)
*
|
2000-03-07 |
2002-10-26 |
일라이 릴리 앤드 캄파니 |
건선의 치료
|
EP1383495A1
(en)
*
|
2001-03-29 |
2004-01-28 |
Eli Lilly And Company |
Duloxetine for treatment of hot flashes
|
HUP0400264A2
(hu)
*
|
2001-06-22 |
2004-08-30 |
Pfizer Products Inc. |
Alacsony oldékonyságú és/vagy savra érzékeny hatóanyagokat és semlegesített savas polimereket tartalmazó gyógyszerkészítmények és eljárás az előállításukra
|
EP1404300B1
(en)
|
2001-06-22 |
2009-09-30 |
Pfizer Products Inc. |
Pharmaceutical compositions of dispersions of drugs and neutral polymers
|
US20050272805A1
(en)
*
|
2002-11-19 |
2005-12-08 |
Detke Michael J |
Treatment of gastrointestinal disorders with duloxetine
|
RU2351315C2
(ru)
*
|
2003-07-24 |
2009-04-10 |
Смитклайн Бичам Корпорейшн |
Пленки, растворяющиеся в полости рта
|
EP1757271A1
(en)
*
|
2004-04-08 |
2007-02-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Solid pharmaceutical preparation with improved stability and process for producing the same
|
GB0410470D0
(en)
*
|
2004-05-11 |
2004-06-16 |
Cipla Ltd |
Pharmaceutical compound and polymorphs thereof
|
JP2007523213A
(ja)
*
|
2004-12-23 |
2007-08-16 |
テバ ファーマシューティカル インダストリーズ リミティド |
医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
|
US7399871B2
(en)
*
|
2005-03-08 |
2008-07-15 |
Teva Pharmaceutical Industries Ltd. |
Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof
|
WO2006099459A1
(en)
*
|
2005-03-14 |
2006-09-21 |
Teva Pharmaceutical Industries Ltd. |
Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
|
EP1904039A2
(en)
*
|
2005-06-20 |
2008-04-02 |
Cadila Healthcare Ltd. |
Controlled release dosage formulation of duloxetine
|
US8153824B2
(en)
*
|
2005-06-22 |
2012-04-10 |
The Wockhardt Company |
Antidepressant oral liquid compositions
|
PL1915137T3
(pl)
|
2005-08-10 |
2014-03-31 |
Add Advanced Drug Delivery Tech Ltd |
Preparat doustny o kontrolowanym uwalnianiu
|
US20060165776A1
(en)
*
|
2005-08-31 |
2006-07-27 |
Ramesh Sesha |
Antidepressant oral pharmaceutical compositions
|
US20080207923A1
(en)
*
|
2005-09-22 |
2008-08-28 |
Santiago Ini |
Pure DNT-maleate and methods of preparation thereof
|
US7842717B2
(en)
*
|
2005-09-22 |
2010-11-30 |
Teva Pharmaceutical Industries Ltd. |
DNT-maleate and methods of preparation thereof
|
EP1951643A1
(en)
*
|
2005-11-23 |
2008-08-06 |
Auspex Pharmaceuticals Inc. |
Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
|
WO2007067581A1
(en)
*
|
2005-12-05 |
2007-06-14 |
Teva Pharmaceutical Industries Ltd. |
2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
|
DE102005060393A1
(de)
*
|
2005-12-16 |
2007-06-21 |
Add Advanced Drug Delivery Technologies Ltd. |
Orales Präparat mit kontrollierter Freisetzung
|
US20070191471A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Santiago Ini |
DNT-fumarate and methods of preparation thereof
|
EP1820800A1
(en)
*
|
2006-02-17 |
2007-08-22 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Crystalline forms of duloxetine hydrochloride and processes for their preparation
|
KR200416582Y1
(ko)
|
2006-03-07 |
2006-05-19 |
김정배 |
건강신발
|
RU2008148547A
(ru)
*
|
2006-05-22 |
2010-06-27 |
Тева Фармасьютикл Индастриес Лтд. (Il) |
Фармацевтические композиции, включающие дулоксетина гидрохлорид с замедленным высвобождением
|
MX2008001079A
(es)
*
|
2006-05-23 |
2008-03-19 |
Teva Pharma |
Polimorfos de hidrocloruro de duloxetina.
|
JP5052051B2
(ja)
*
|
2006-06-16 |
2012-10-17 |
トーアエイヨー株式会社 |
腸溶性顆粒剤及びその製造方法
|
US20090175935A1
(en)
*
|
2006-08-14 |
2009-07-09 |
Torrent Research Ltd. |
Pharmaceutical compositions of duloxetine
|
CN101190208B
(zh)
*
|
2006-11-30 |
2011-11-02 |
石药集团中奇制药技术(石家庄)有限公司 |
一种含有盐酸度洛西汀的药物制剂及其制备方法
|
CN101657438A
(zh)
|
2006-12-22 |
2010-02-24 |
斯索恩有限公司 |
制备度洛西汀和相关化合物的方法
|
WO2008077939A2
(en)
*
|
2006-12-27 |
2008-07-03 |
Lek Pharmaceuticals D.D. |
Duloxetine composition
|
EP1938840A1
(en)
*
|
2006-12-27 |
2008-07-02 |
LEK Pharmaceuticals D.D. |
Duloxetine composition
|
EP2018860A1
(en)
*
|
2007-07-16 |
2009-01-28 |
LEK Pharmaceuticals D.D. |
Duloxetine composition
|
US20080226711A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Torrent Pharmaceuticals Ltd. |
Pharmaceutical compositions of duloxetine
|
US9358213B2
(en)
*
|
2007-04-20 |
2016-06-07 |
Wockhardt Limited |
Pharmaceutical compositions of duloxetine
|
WO2009004649A2
(en)
*
|
2007-05-21 |
2009-01-08 |
Sun Pharmaceutical Industries Limited |
Enteric coated pharmaceutical compositions
|
GB0712220D0
(en)
*
|
2007-06-23 |
2007-08-01 |
Arrow Int Ltd |
Duloxetine formulation
|
WO2009066181A2
(en)
*
|
2007-07-09 |
2009-05-28 |
Combino Pharm, S.L. |
Oral delayed-release duloxentine hydrochloride pellets
|
EP2182929A2
(en)
*
|
2007-07-13 |
2010-05-12 |
Synthon B.V. |
Duloxetine formulations
|
WO2009087657A2
(en)
*
|
2007-11-03 |
2009-07-16 |
Alkem Laboratories Ltd. |
Stable pharmaceutical composition of duloxetine and process for its preparation
|
EP2231169B1
(en)
*
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
AU2009206204B2
(en)
*
|
2008-01-25 |
2015-03-19 |
Alphapharm Pty Ltd |
Delayed release pharmaceutical composition of duloxetine
|
US20090226517A1
(en)
*
|
2008-02-06 |
2009-09-10 |
Vinita Umashankar Vyas |
Pharmaceutical formulations comprising duloxetine
|
WO2009118756A2
(en)
*
|
2008-03-24 |
2009-10-01 |
Lupin Limited |
Delayed release compositions of duloxetine
|
WO2009136398A2
(en)
*
|
2008-05-06 |
2009-11-12 |
Dexcel Ltd |
Stable benzimidazole formulation
|
EP2133072A1
(en)
|
2008-06-13 |
2009-12-16 |
KRKA, D.D., Novo Mesto |
Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
|
US20100040680A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Felix Lai |
Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation
|
ES2376095B1
(es)
*
|
2008-10-02 |
2013-01-24 |
Laboratorios Del Dr. Esteve, S.A. |
Pellets entéricos de duloxetina.
|
CN101756960B
(zh)
|
2008-12-26 |
2012-06-27 |
上海中西制药有限公司 |
一种度洛西汀肠溶制剂及其芯材和制备方法
|
WO2010078878A1
(en)
*
|
2009-01-12 |
2010-07-15 |
Synthon B.V. |
Duloxetine formulations
|
CA2765635C
(en)
|
2009-06-25 |
2016-09-06 |
Wockhardt Research Centre |
Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
|
DE102009033621A1
(de)
|
2009-07-17 |
2011-01-20 |
Add Technologies Ltd. |
Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen
|
WO2011039768A2
(en)
*
|
2009-09-17 |
2011-04-07 |
Cadila Healthcare Limited |
Pharmaceutical compositions for reducing alcohol-induced dose dumping
|
DK2512455T3
(da)
*
|
2009-12-18 |
2014-03-24 |
Frieslandcampina Nederland Holding B V |
Sambehandlet tablethjælpestofsammensætning, dens fremstilling og anvendelse
|
CN102869349A
(zh)
*
|
2010-03-09 |
2013-01-09 |
阿尔科米斯制药爱尔兰有限公司 |
耐酒精的肠溶药物组合物
|
EP2377525A1
(en)
|
2010-03-26 |
2011-10-19 |
Laboratorios del Dr. Esteve S.A. |
Duloxetine enteric pellets
|
ES2601841T3
(es)
*
|
2010-05-25 |
2017-02-16 |
Hetero Research Foundation |
Composición farmacéutica oral de duloxetina
|
CN102908331A
(zh)
*
|
2011-08-01 |
2013-02-06 |
浙江九洲药物科技有限公司 |
一种盐酸度洛西汀肠溶胶囊及其制备方法
|
EP2659881B1
(en)
|
2012-04-30 |
2017-11-29 |
Tillotts Pharma Ag |
A delayed release drug formulation
|
CA2870134C
(en)
|
2012-05-02 |
2020-04-28 |
Capsugel France SAS |
Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
|
CN103505421B
(zh)
*
|
2012-06-29 |
2018-04-27 |
石药集团中奇制药技术(石家庄)有限公司 |
一种盐酸度洛西汀的肠溶微丸制剂
|
CN103211777A
(zh)
*
|
2013-03-31 |
2013-07-24 |
北京万全阳光医学技术有限公司 |
一种盐酸度洛西汀的药物制剂及其制备的方法
|
GR1008228B
(el)
*
|
2013-04-23 |
2014-06-16 |
"Φαρματεν Α.Β.Ε.Ε.", |
Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
|
EP2813218B1
(en)
*
|
2013-06-14 |
2022-08-24 |
Shin-Etsu Chemical Co., Ltd. |
Method for producing aqueous enteric coating liquid, solid preparation, and method for producing same
|
CN103393615B
(zh)
*
|
2013-07-24 |
2015-07-15 |
海南华益泰康药业有限公司 |
一种度洛西汀肠溶小丸及其制备方法
|
PL224543B1
(pl)
|
2013-08-21 |
2017-01-31 |
Pabianickie Zakłady Farm Polfa Spółka Akcyjna |
Dojelitowa tabletka duloksetyny
|
MA38847B2
(fr)
|
2013-10-29 |
2021-02-26 |
Tillotts Pharma Ag |
Formulation médicamenteuse à libération retardée
|
US20160256399A1
(en)
|
2013-11-04 |
2016-09-08 |
Capsugel Belgium Nv |
Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
|
CN106456555B
(zh)
*
|
2014-05-20 |
2019-05-07 |
陶氏环球技术有限责任公司 |
包含酯化纤维素醚的胶囊壳
|
EP3182970A4
(en)
*
|
2014-08-22 |
2018-03-21 |
Medipath Inc. |
Compositions and methods for cannabinoid coatings for use in drug delivery
|
US10471152B2
(en)
*
|
2014-08-29 |
2019-11-12 |
Capsugel Belgium Nv |
Colloidal dispersion comprising HPMCAS
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
US9668975B2
(en)
|
2014-10-14 |
2017-06-06 |
PharmaDax Inc. |
Method of preparing drug agglomerate
|
CN105726488B
(zh)
*
|
2014-12-08 |
2020-10-20 |
上海爱科百发生物医药技术有限公司 |
含有呼吸道合胞病毒抑制剂的肠溶微丸及其制备方法
|
KR101625344B1
(ko)
|
2015-12-21 |
2016-06-08 |
주식회사 유영제약 |
세레콕시브 및 둘록세틴을 함유하는 약제학적 조성물
|
CN105534949A
(zh)
*
|
2016-01-06 |
2016-05-04 |
北京修正创新药物研究院有限公司 |
一种盐酸度洛西汀的肠溶微丸制剂
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
JP6815109B2
(ja)
*
|
2016-06-23 |
2021-01-20 |
キョーリンリメディオ株式会社 |
デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物
|
JP6856326B2
(ja)
*
|
2016-07-15 |
2021-04-07 |
富士化学工業株式会社 |
腸放出粒子組成物
|
CN106166144A
(zh)
*
|
2016-08-12 |
2016-11-30 |
海南合瑞制药股份有限公司 |
一种盐酸度洛西汀肠溶胶囊药物组合物
|
JP2018172361A
(ja)
*
|
2016-10-14 |
2018-11-08 |
大原薬品工業株式会社 |
光安定性を改善した、デュロキセチンを含有する固形製剤
|
US9839626B1
(en)
|
2016-12-14 |
2017-12-12 |
Sun Pharmaceutical Industries Limited |
Duloxetine sprinkles
|
JP7072431B2
(ja)
*
|
2017-04-14 |
2022-05-20 |
富士化学工業株式会社 |
錠剤及びその製造方法
|
JP6972674B2
(ja)
*
|
2017-06-06 |
2021-11-24 |
ニプロ株式会社 |
経口医薬製剤
|
JP2020029447A
(ja)
*
|
2018-06-25 |
2020-02-27 |
大原薬品工業株式会社 |
腸溶性高分子及び抗付着剤を含有する顆粒
|
CN115844846A
(zh)
*
|
2018-10-25 |
2023-03-28 |
上海上药中西制药有限公司 |
盐酸度洛西汀肠溶制剂、其主药层及其混悬液、其隔离层及其包衣液、及其制备方法
|
JP7050714B2
(ja)
*
|
2019-04-04 |
2022-04-08 |
信越化学工業株式会社 |
腸溶性コーティング用組成物及び固形製剤の製造方法
|
JP2020189815A
(ja)
*
|
2019-05-23 |
2020-11-26 |
東和薬品株式会社 |
デュロキセチン製剤およびその安定化方法
|
EP4025206A1
(en)
|
2019-09-02 |
2022-07-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and compositions for treating pax6- deficiency related disease
|
WO2021126098A1
(en)
*
|
2019-12-18 |
2021-06-24 |
Santa Farma İlaç Sanayi̇ A.Ş. |
Gastro-resistant pellet comprising duloxetine
|
WO2021126099A1
(en)
*
|
2019-12-18 |
2021-06-24 |
Santa Farma İlaç Sanayi̇ A.Ş. |
An enteric coated pellet comprising duloxetine hydrochloride with optimized degrees of neutralization
|
WO2022115054A1
(en)
*
|
2020-11-27 |
2022-06-02 |
Santa Farma Ilac Sanayii A.S. |
Enteric coated duloxetine compositions
|